CorMedix Inc. (CRMD) stock dropped 11% after reporting mixed Q4 results. While revenue jumped 312% to $128.6 million, earnings per share of $0.16 missed the $0.82 consensus estimate. Despite the revenue beat, a significant increase in operating expenses weighed on the stock's performance.